Can we produce an image of bacteria with radiopharmaceuticals?

Akhtar MS, Khan ME, Khan B, Irfanullah J, Afzal MS, Khan MA, et al. An imaging analysis of 99mTc-UBI (29–41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging 2008. DOI 10.1007/s00259-007-0671-3. Welling M, Stokkel M, Balter J, Sarda-Mantel L, Meulemans A, Le Guludec D. The many roads to infection imaging. Eur J Nucl Med Mol Imaging 2008;35. DOI 10.1007/s00259-007-0695-8. Lucignani G. The many roads to infection imaging. Eur J Nucl Med Mol Imaging. 2007;34(11):1873–7. Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H, Bhatnagar A, et al. Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton). J Clin Pathol. 2002;55:817–823. Hall AV, Solanki KK, Vinjamuri S, et al. Evaluation of 99mTc-Infecton, a novel agent for detecting site of infection. J Clin Pathol. 1996;51:215–219. Sarda L, Saleh-Mghir A, Peker C, Meulemans A, Crémieux AC, Le Guludec D. Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med. 2002;43(2):239–45. Sarda L, Crémieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44(6):920–6. Siaens RH, Rennen HJ, Boerman OC, Dierckx R, Slegers G. Synthesis and comparison of Tc-99m-enrofloxacin and Tc-99m-ciprofloxacin. J Nucl Med. 2004;45(12):2088–94. Langer O, Brunner M, Zeitlinger M, Ziegler S, Müller U, Dobrozemsky G, et al. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging. 2005;32(2):143–50. Singh AK, Verma J, Bhatnagar A, Ali A. Tc-99m labeled sparfloxacin: a specific infection imaging agent. W J Nucl Med. 2003;2(2):103–109. Martin-Comin J, Soroa V, Rabiller G, Galli R, Cuesta L, Roca M. Diagnosis of bone infection with 99mTc-ceftizoxime. Rev Esp Med Nucl. 2004;23(5):357. Gomes Barreto V, Rabiller G, Iglesias F, Soroa V, Tubau F, Roca M, et al. 99mTc-ceftizoxime scintigraphy in normal rats and abscess induced rats. Rev Esp Med Nucl. 2005;24(5):312–8. Fischman AJ, Livni E, Babich J, Alpert NM, Liu YY, Thom E, et al. Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography. Antimicrob Agents Chemother. 1992;36(10):2286–92. Singh AK, Verma J, Bhatnagar A, Sen S, Bose M. Tc-99 isoniazid: a specific agent for diagnosis of tuberculosis. W J Nucl Med. 2003;2:292–305. Causse JE, Pasqualini R, Cypriani B, Weil R, Van der Valk R, Bally P, et al. Labelling of ethambutol with 99mTc; using a new reduction procedure. Pharmacokinetic study in the mouse and rat. Int J Rad Appl Instrum (A). 1990;41(5):493–6. Lupetti A, Welling MM, Pauwels EK, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis. 2003;3(4):223–9. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42(5):788–94. Lupetti A, Pauwels EKJ, Nibbering PH, Welling MM. 99mTc-antimicrobial peptides: promising candidates for infection imaging. Q J Nucl Med. 2003;47:258–45. Nibbering PH, Welling M, van den Broek PJ, Pauwels EKJ. Radiolabelled antimicrobial peptides for imaging of infection: a review. Nucl Med Comm. 1998;19:1117–21. Dec. Meléndez-Alafort L, Rodrìguez-Cortés J, Ferro-Flores G, Murphy CA, Herrera-Rodrìguez R, Martìnez-Duncker C. Biokinetics of 99mTc-UBI in humans. Nucl Med Biol. 2004;31:373–9. Akhtar MS, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Khan B, et al. 99mTc-labeled antimicrobial peptide ubiquicidin (29–41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849–856. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292–301. Zijlstra S, Gunawan J, Freytag C, Burchert W. Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet. Appl Radiat Isot. 2006;64(7):802–7. Welling MM, Nibbering PH, Paulusma-Annema A, Hiemstra PS, Pauwels EK, Calame W. Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med. 1999;40:2073–80. Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ. Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med. 2004;45(7):1201–8. Lazzeri E, Erba P, Perri M, Tascini C, Doria R, Giorgetti J, et al. The scintigraphic imaging of vertebral osteomyelitis with 111In-biotin. Spine 2008 (in press). Zasloff M. Antimicrobial peptides of multicellular organism. Nature. 2002;415:389–95. Cudic M, Otvos L. Intracellular targets of antimicrobial peptides. Current Drug Targets. 2002;3:101–6. Hancock REW, Rozek A. Role of membrane in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett. 2002;206:143–9. Alexander K, Drost WT, Mattoon JS, Kowalski JJ, Funk JA, Crabtree AC. Binding of ciprofloxacin labelled with technetium Tc 99m versus 99mTc-pertechnetate to a live and killed equine isolate of Escherichia coli. Can J Vet Res. 2005;69(4):272–7. Sistrom WR. Microbial life. New York: Holt, Rinehart and Winston; 1969. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183(18):5385–94. Zimmerli W, Trampuz A, Ochsner P. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54. Bounds SJ, Nakkula R, Walters JD. Fluoroquinolone transport by human monocytes: characterization and comparison to other cells of myeloid lineage. Antimicrob Agents Chemother. 2000;44(10):2609–14. Oct. Walters JD, Zhang F, Nakkula RJ. Mechanisms of fluoroquinolone transport by human neutrophils. Antimicrob Agents Chemother. 1999;43(11):2710–5. Nov. Walters JD, Nakkula RJ. Ciprofloxacin transport by chemoattractant-activated polymorphonuclear leukocytes: regulation by priming and protein kinase C. Antimicrob Agents Chemother. 2003;47(10):3345–8. Oct. Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1982;21(3):373–80. Mar.